Women's Health

Veozah

starting at $699.99

Veozah is a non-hormonal medication used to treat the vasomotor symptoms associated with menopause. It helps regulate body temperature to reduce the severity of hot flashes and night sweats, resulting in significant improvements in symptoms over a 24-hour period after 4 weeks of use compared to placebo..

The first non-hormonal, prescription regimen for vasomotor symptoms associated with menopause

A once daily oral tablet that helps regulate body temperature

Taken with or without food at the same time each day for best results

Healthy liver functioning and baseline tests are recommended before starting Veozah

Refill

HSA/FSA Eligible

Veozah

H&P Certification

Tell us about yourself.

“You need to carefully review and make sure you can agree to each statement. If there are questions, a doctor will be in touch after checkout.”

Veozah

By clicking the “I Agree” button below, you certify under penalty of perjury that the following statements are true and correct and understand that a medical provider will rely on the truthfulness of your statements when determining whether a prescription is warranted and appropriate.

I agree that I:

am 18 years or older
have not had a hypersensitivity reaction to Veozah or any component of the formulation
am not pregnant or breastfeeding
do not have liver (hepatic) impairment or liver cirrhosis
understand this medication is contraindicated in all stages and forms of liver impairment, including mild to severe impairment
will discontinue this medication if experiencing severe side effects such as dark urine, yellowing skin, tiredness, or signs of allergic reaction
do not have kidney (renal) impairment (GFR > 30 mL/min/1.73 m2) or end stage renal disease
understand this medication has drug interactions that could enhance the side effects of this medication resulting in elevated liver function tests. Major interactions occur with, but are not limited to, the following medications: acyclovir, caffeine, ciprofloxacin, disulfiram, estradiol, fluvoxamine, propranolol, valacyclovir, and verapamil.
understand this is not a comprehensive list of precautions, risks, side effects, or details about taking this medication
understand that only major drug interactions are listed and have not been reviewed against the other medications, supplements, or herbal products I may be taking unless also filled by TelyRx

understand that TelyRx LLC does not provide medical care and the providers who use TelyRx to provide telehealth services (“Telehealth Providers”) should not replace your primary provider.
understand that the Telehealth Providers are not able to: (1) monitor ongoing health or lab values for side effects or efficacy, (2) observe how you (or your pet) tolerate any prescribed treatment, or (3) determine if the prescribed treatment is working as intended and assume any risks associated with this modality of care and waive any claim I may have in the future against TelyRx and/or the Telehealth Providers.
understand that by using this site, I have created a patient-client-doctor relationship and I am being directed by the Telehealth Providers to consult my primary provider soon after beginning any treatment prescribed by the Telehealth Providers.
understand that this is a supplemental mode of care for your convenience and the Telehealth Providers are not to be used, or relied on, as a replacement for in-person follow-up visits or interactions with your primary provider.

I agree that all statements above are true and my physician visit is complete.

Cancel

Web-form is not active.

Skip to the end of the images gallery

For illustration purposes only. Product appearance may vary based on manufacturer availability.

Skip to the beginning of the images gallery

Side Effects

Veozah (fezolinetant) is a non-hormonal medication approved for treating moderate to severe vasomotor symptoms (hot flashes) associated with menopause. Common side effects include abdominal pain, diarrhea, insomnia, back pain, and hot flashes or hot flushes. A significant concern is the potential for rare but serious liver injury, prompting the FDA to require liver function tests before starting treatment and at months 3, 6, and 9 during therapy. Signs of liver problems may include fatigue, nausea, vomiting, itching, yellowing of the skin or eyes (jaundice), pale stools, dark urine, and upper abdominal pain. Patients experiencing these symptoms should stop taking Veozah and contact their healthcare provider immediately. Due to these risks, Veozah is not recommended for individuals with cirrhosis, severe kidney issues, or those taking certain CYP1A2 inhibitors.
Consumer Information Use and Disclaimer

This information should not be used to decide whether or not to take this medicine or any other medicine. Only a healthcare provider has the knowledge and training to decide which medicines are right for you. TelyRx does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a limited summary of general information about the medicine’s uses from the patient education materials and is not intended to be comprehensive. This limited summary does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not intended to provide medical advice, diagnosis or treatment and does not replace information you may receive from your healthcare provider. For a more detailed summary of information about the risks and benefits of using this medicine, please review the entire patient education information you receive with the medication.